Literature DB >> 9069491

Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)

M Yamamoto, H Ujike, K Wada, T Tsuji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9069491      PMCID： PMC1064165          DOI： 10.1136/jnnp.62.3.290

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Is Parkinson's disease a mitochondrial disorder?

Authors:  Y Nakagawa-Hattori; H Yoshino; T Kondo; Y Mizuno; S Horai
Journal:  J Neurol Sci       Date:  1992-01       Impact factor: 3.181

2.  Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity.

Authors:  S Przedborski; V Jackson-Lewis; U Muthane; H Jiang; M Ferreira; A B Naini; S Fahn
Journal:  Ann Neurol       Date:  1993-11       Impact factor: 10.422

3.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome.

Authors:  S G Pavlakis; P C Phillips; S DiMauro; D C De Vivo; L P Rowland
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

4.  Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease.

Authors:  D Bravi; J J Anderson; F Dagani; T L Davis; R Ferrari; M Gillespie; T N Chase
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

5.  Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion.

Authors:  Y Mizuno; T Saitoh; N Sone
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

Review 6.  Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.

Authors:  A H Schapira
Journal:  Mov Disord       Date:  1994-03       Impact factor: 10.338

7.  Deficiency of subunits of Complex I and mitochondrial encephalomyopathy.

Authors:  T Ichiki; M Tanaka; M Nishikimi; H Suzuki; T Ozawa; M Kobayashi; Y Wada
Journal:  Ann Neurol       Date:  1988-03       Impact factor: 10.422
  7 in total
  4 in total

1.  Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Authors:  William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Journal:  J Neurol Sci       Date:  2008-09-09       Impact factor: 3.181

2.  Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

Authors:  William T Regenold; Pornima Phatak; Christopher M Marano; Amritpal Sassan; Robert R Conley; Mitchel A Kling
Journal:  Biol Psychiatry       Date:  2008-12-21       Impact factor: 13.382

3.  Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients.

Authors:  William T Regenold; K Calvin Hisley; Pornima Phatak; Christopher M Marano; Abraham Obuchowski; David M Lefkowitz; Amritpal Sassan; Sameer Ohri; Tony L Phillips; Narveen Dosanjh; Robert R Conley; Rao Gullapalli
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

4.  parkin-induced defects in neurophysiology and locomotion are generated by metabolic dysfunction and not oxidative stress.

Authors:  Amanda Vincent; Laura Briggs; Griff F J Chatwin; Elizabeth Emery; Rose Tomlins; Matt Oswald; C Adam Middleton; Gareth J O Evans; Sean T Sweeney; Christopher J H Elliott
Journal:  Hum Mol Genet       Date:  2012-01-03       Impact factor: 6.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.